AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spire Healthcare Group PLC

Director's Dealing Apr 27, 2022

5328_dirs_2022-04-27_51507e29-85f9-42b3-a7e7-618298727ea7.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5823J

Spire Healthcare Group PLC

27 April 2022

27 April 2022

Spire Healthcare Group plc

Grant of Sharesave Plan Options

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

Spire Healthcare Group plc (the "Company") announces that following valid elections by the PDMRs disclosed in the table below to participate in the Company's all-employee Sharesave Plan, options over the Company's ordinary shares of 1p each ("Ordinary Shares") were granted on 26 April 2022 as follows:

Directors Number of Ordinary Shares under Option Exercise Price per Ordinary Share
Justin Ash 1,818 £1.98
Jitesh Sodha 1,818 £1.98
Other PDMRs Number of Ordinary Shares under Option Exercise Price per Ordinary Share
John Forrest 1,818 £1.98
Harbant Samra 1,818 £1.98

Subject to the rules of the Spire Healthcare Group plc 2016 Sharesave Plan, the options may be exercised at the end of the three year saving contract at the exercise price set out above.  The expected maturity date of these options is 1 June 2025 and they will remain exercisable until 30 November 2025.

Name of contact and telephone number for queries:

Philip Davies                                                            07803 508348

Company Secretary

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1 pence each

GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information

- Aggregated volume

- Price
As above
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Jitesh Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1 pence each

GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information

- Aggregated volume

- Price
As above
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name John Forrest
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1 pence each

GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information

- Aggregated volume

- Price
As above
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Harbant Samra
2 Reason for the notification
a) Position/status Interim Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1 pence each

GB00BNLPYF73
b) Nature of the transaction Grant of options under the Spire Healthcare Group plc Sharesave plan
c) Price(s) and volume(s) Price(s) Volume(s)
£1.98 1,818
d) Aggregated information

- Aggregated volume

- Price
As above
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSGDSISDDGDR

Talk to a Data Expert

Have a question? We'll get back to you promptly.